Review





Similar Products

95
MedChemExpress bleb
Bleb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/(-)-Blebbistatin/pmc13081057-409-5-6
Average 95 stars, based on 1 article reviews
bleb - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

95
MedChemExpress blebbistatin bleb
Blebbistatin Bleb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/Blebbistatin/pmc13081057-167-0-3
Average 95 stars, based on 1 article reviews
blebbistatin bleb - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Beyotime non-muscle myosin iia inhibitor blebbistatin bleb
Non Muscle Myosin Iia Inhibitor Blebbistatin Bleb, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/non+muscle+myosin+iia+inhibitor+blebbistatin+bleb/pm39733514-64-1-7
Average 90 stars, based on 1 article reviews
non-muscle myosin iia inhibitor blebbistatin bleb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
Selleck Chemicals blebbistatin bleb

Blebbistatin Bleb, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/(-)-Blebbistatin/pmc11530898-5-0-3
Average 95 stars, based on 1 article reviews
blebbistatin bleb - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Cayman Chemical blebbistatin bleb
( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or <t>Blebbistatin</t> (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].
Blebbistatin Bleb, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/blebbistatin/pmc10715734-346-0-4
Average 90 stars, based on 1 article reviews
blebbistatin bleb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Millipore blebbistatin (bleb
(A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of <t>blebbistatin,</t> an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
Blebbistatin (Bleb, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/blebbistatin/pmc03428312-260-30-33
Average 90 stars, based on 1 article reviews
blebbistatin (bleb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
PeproTech blebbistatin (bleb)
(A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of <t>blebbistatin,</t> an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
Blebbistatin (Bleb), supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blebbistatin+bleb/blebbistatin/pm35929298-143-14-16
Average 90 stars, based on 1 article reviews
blebbistatin (bleb) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Journal: STAR Protocols

Article Title: Protocol for the dissociation of adult human primary cardiomyocytes using a methylcellulose-supplemented digestion solution

doi: 10.1016/j.xpro.2024.103379

Figure Lengend Snippet:

Article Snippet: (−)-blebbistatin (Bleb) , Selleck , S7099.

Techniques: Recombinant, Hood, Microscopy, Blocking Assay, Transferring, Membrane

( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or Blebbistatin (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].

Journal: eLife

Article Title: N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters

doi: 10.7554/eLife.87833

Figure Lengend Snippet: ( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or Blebbistatin (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].

Article Snippet: Blebbistatin (Bleb, 50 μM, Cayman Chemicals) was used to inhibit the NMII motor activity ( ).

Techniques: Expressing, Incubation, Fluorescence, Microscopy, Generated, Membrane, Control, Knock-Out, Staining

Journal: eLife

Article Title: N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters

doi: 10.7554/eLife.87833

Figure Lengend Snippet:

Article Snippet: Blebbistatin (Bleb, 50 μM, Cayman Chemicals) was used to inhibit the NMII motor activity ( ).

Techniques: Control, Liposomes, Antibody Labeling, Software

(A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of blebbistatin, an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.

Journal: PLoS ONE

Article Title: Rho-ROCK and Rac-PAK Signaling Pathways Have Opposing Effects on the Cell-to-Cell Spread of Marek's Disease Virus

doi: 10.1371/journal.pone.0044072

Figure Lengend Snippet: (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1

Article Snippet: Stock solutions were made in dimethyl sulfoxide (DMSO) for: cytochalasin D (CytD) (C8273, Sigma) at 20 mM, jasplakinolide (Jaspl) (J7473, Invitrogen) at 1 mM, IPA-3 (cat#506106, Calbiochem) at 20 mM, blebbistatin (Bleb) (B0560, Sigma) at 25 mM.

Techniques: Staining, Infection, Western Blot, Labeling, Activity Assay, Concentration Assay